CPTAC System Suitability (CompRef) Study: Proteome, VU

ABSTRACT: The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC). Please include this attribution in publications, "Data used in this publication was created by the Clinical Proteomics Tumor Analysis Consortium (NCI/NIH)."

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

DISEASE(S): Breast Cancer

SUBMITTER: Nathan Edwards  

LAB HEAD: Daniel C. Liebler, Ph.D.

PROVIDER: PXD001006 | Pride | 2014-09-16

REPOSITORIES: Pride